Equities

Aadi Bioscience Inc

Aadi Bioscience Inc

Actions
  • Price (EUR)1.66
  • Today's Change0.01 / 0.61%
  • Shares traded1.25k
  • 1 Year change-67.13%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments109173149
Total Receivables, Net5.491.86--
Total Inventory6.431.86--
Prepaid expenses3.833.752.28
Other current assets, total------
Total current assets125180151
Property, plant & equipment, net5.972.030.61
Goodwill, net------
Intangibles, net--03.81
Long term investments------
Note receivable - long term------
Other long term assets1.802.182.21
Total assets132184158
LIABILITIES
Accounts payable5.903.526.44
Accrued expenses15158.58
Notes payable/short-term debt000.26
Current portion long-term debt/capital leases------
Other current liabilities, total5.76----
Total current liabilities261915
Total long term debt005.76
Total debt006.02
Deferred income tax------
Minority interest------
Other liabilities, total0.837.020.47
Total liabilities272622
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital374362279
Retained earnings (accumulated deficit)(269)(203)(143)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.03(0.12)--
Total equity105158136
Total liabilities & shareholders' equity132184158
Total common shares outstanding252421
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.